Cargando…

Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma

The sensitivity of patient-reported outcomes (PROs) to detect the effects of treatment change depends on the match between the change in items of the PRO and the change that takes place in a sample of people. The aim of this study is to compare the sensitivity of different PROs in detecting changes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyland, Michael E, Lanario, Joseph W, Menzies-Gow, Andrew, Mansur, Adel H, Dodd, James W, Fowler, Stephen J, Hayes, Gemma, Jones, Rupert C, Masoli, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477679/ https://www.ncbi.nlm.nih.gov/pubmed/34565203 http://dx.doi.org/10.1177/14799731211043530

Ejemplares similares

Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)
por: Lanario, Joseph W., et al.
Publicado: (2020)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

The construction and validation of the Severe Asthma Questionnaire
por: Hyland, Michael E., et al.
Publicado: (2018)

“Life-changing”: the experience of super-responders to biologics in severe asthma
por: Lanario, Joseph W., et al.
Publicado: (2022)

Evidence for similarity in symptoms and mechanism: The extra‐pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia
por: Hyland, Michael E., et al.
Publicado: (2019)

How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma
por: Hyland, Michael E., et al.
Publicado: (2018)

Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma
por: de Felice, Giulio, et al.
Publicado: (2021)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
por: Niven, Robert M, et al.
Publicado: (2016)

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013)

Benefits of specialist severe asthma management: demographic and geographic disparities
por: Redmond, Charlene, et al.
Publicado: (2022)

The Biology of Eosinophils and Their Role in Asthma
por: McBrien, Claire N., et al.
Publicado: (2017)

Use of Health Related Quality of Life in Clinical Trials for Severe Asthma: A Systematic Review
por: Lanario, Joseph W, et al.
Publicado: (2021)

Defining severe asthma – an approach to find new therapies
por: Nanzer, Alexandra M., et al.
Publicado: (2014)

Statistical Cluster Analysis of the British Thoracic Society Severe Refractory Asthma Registry: Clinical Outcomes and Phenotype Stability
por: Newby, Chris, et al.
Publicado: (2014)

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma
por: Haughney, John, et al.
Publicado: (2023)

Global Quality Standard for Identification and Management of Severe Asthma
por: Haughney, John, et al.
Publicado: (2020)

A Charter to Improve Patient Care in Severe Asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2018)

Holy Grail: the journey towards disease modification in asthma
por: Busse, William W., et al.
Publicado: (2022)

Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics
por: Porsbjerg, Celeste M., et al.
Publicado: (2020)

The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
por: Smith, Steven J., et al.
Publicado: (2021)

Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores
por: Menzies-Gow, Andrew, et al.
Publicado: (2017)

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma
por: Busby, John, et al.
Publicado: (2022)

Long‐term corticosteroid use, adrenal insufficiency and the need for steroid‐sparing treatment in adult severe asthma
por: Gurnell, M., et al.
Publicado: (2021)

Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
por: Menzies-Gow, Andrew, et al.
Publicado: (2020)

Audit in Acute Severe Asthma—Who Benefits?
por: Harrison, B D W, et al.
Publicado: (1993)

Effect of benralizumab in a patient with uncontrolled severe eosinophilic asthma and comorbid chronic rhinosinusitis with nasal polyps refractory to mepolizumab treatment
por: Mansur, Adel H.
Publicado: (2021)

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021)

Symptom frequency and development of a generic functional disorder symptom scale suitable for use in studies of patients with irritable bowel syndrome, fibromyalgia syndrome or chronic fatigue syndrome
por: Hyland, Michael E., et al.
Publicado: (2019)

Targeting TSLP in Asthma
por: Parnes, Jane R, et al.
Publicado: (2022)

Bacteria in sputum of stable severe asthma and increased airway wall thickness
por: Zhang, Qingling, et al.
Publicado: (2012)

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
por: Bleecker, Eugene R., et al.
Publicado: (2018)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
por: Menzies-Gow, Andrew N, et al.
Publicado: (2022)

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry
por: Sweeney, Joan, et al.
Publicado: (2012)

Management of difficult-to-treat asthma in adolescence and young adults
por: Mansur, Adel H., et al.
Publicado: (2023)

Biological treatments for severe asthma
por: Jin, Hyun Jung
Publicado: (2020)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9i7u7921r0hml3nthh05l2tue0